Suppr超能文献

评估 VITEK MS 知识库版本 3.0 对临床相关分枝杆菌种属的鉴定能力。

Evaluation of the VITEK MS knowledge base version 3.0 for the identification of clinically relevant Mycobacterium species.

机构信息

Department of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, 200433, China.

Tongji University School of Medicine, Shanghai, 200092, China.

出版信息

Emerg Microbes Infect. 2018 Jul 4;7(1):114. doi: 10.1038/s41426-018-0120-3.

Abstract

Different Mycobacterium spp. infections may indicate varied treatment regimens in the clinic. Thus, the species-level identification of Mycobacterium spp. is one of the most important tasks for a clinical microbiology laboratory. Although matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) has emerged as a rapid and accurate method for the identification of mycobacteria, this method lacks a comprehensive evaluation of the identification accuracy for clinically collected mycobacteria using VITEK MS Knowledge Base Version 3.0 (Ver 3.0). The objectives of the present study were to evaluate the identification performance of Mycobacterium spp. using Ver 3.0 and a sample processing kit for strain inactivation and protein extraction. Among the 507 Mycobacterium isolates, 46 isolates were M. tuberculosis, and 461 isolates were nontuberculous mycobacteria (NTM) (including 27 species: 17 species were slowly growing mycobacteria (SGM), and 10 species were rapidly growing mycobacteria (RGM)). The VITEK MS V3.0 library was used to correctly identify 476/507 (93.9%) isolates (425 isolates were correctly identified initially, and 51 more isolates were correctly identified on repeat), 23/507 (4.5%) isolates were unidentified, and 8/507 (1.6%) isolates were misidentified. In summary, we showed that Mycobacterium spp. can be adequately identified by Ver 3.0 in combination with the use of a standard sample processing kit.

摘要

不同的分枝杆菌属感染可能表明在临床上有不同的治疗方案。因此,分枝杆菌属的种水平鉴定是临床微生物学实验室最重要的任务之一。虽然基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)已成为鉴定分枝杆菌的快速准确方法,但该方法缺乏对使用 VITEK MS 知识库版本 3.0(Ver 3.0)对临床收集的分枝杆菌进行鉴定准确性的全面评估。本研究的目的是评估使用 Ver 3.0 和用于菌株灭活和蛋白质提取的样品处理试剂盒鉴定分枝杆菌属的性能。在 507 株分枝杆菌分离株中,46 株为结核分枝杆菌,461 株为非结核分枝杆菌(NTM)(包括 27 个种:17 个为缓慢生长分枝杆菌(SGM),10 个为快速生长分枝杆菌(RGM))。VITEK MS V3.0 库用于正确鉴定 476/507(93.9%)株(425 株最初被正确鉴定,51 株重复鉴定),23/507(4.5%)株未鉴定,8/507(1.6%)株被错误鉴定。总之,我们表明 Ver 3.0 结合使用标准样品处理试剂盒可以充分鉴定分枝杆菌属。

相似文献

3
Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory.
Microbiol Spectr. 2022 Dec 21;10(6):e0201822. doi: 10.1128/spectrum.02018-22. Epub 2022 Oct 26.

引用本文的文献

1
Evaluation of nucleotide MALDI-TOF-MS for the identification of species.
Front Cell Infect Microbiol. 2024 Feb 6;14:1335104. doi: 10.3389/fcimb.2024.1335104. eCollection 2024.
2
infection successfully treated with clarithromycin, rifampicin, and ethambutol.
Respir Med Case Rep. 2023 Jul 8;45:101894. doi: 10.1016/j.rmcr.2023.101894. eCollection 2023.
3
Characteristics of clinical isolates of nontuberculous mycobacteria in Java-Indonesia: A multicenter study.
PLoS Negl Trop Dis. 2022 Dec 27;16(12):e0011007. doi: 10.1371/journal.pntd.0011007. eCollection 2022 Dec.
5
Performance evaluation and clinical validation of optimized nucleotide MALDI-TOF-MS for mycobacterial identification.
Front Cell Infect Microbiol. 2022 Dec 2;12:1079184. doi: 10.3389/fcimb.2022.1079184. eCollection 2022.
6
Performance of MALDI-TOF Mass Spectrometry in the Philippines.
Trop Med Infect Dis. 2021 Jun 26;6(3):112. doi: 10.3390/tropicalmed6030112.
7
Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey.
Infect Dis Poverty. 2021 Apr 29;10(1):59. doi: 10.1186/s40249-021-00844-1.

本文引用的文献

1
Treatment of Non-Tuberculous Mycobacterial Lung Disease.
Curr Treat Options Infect Dis. 2016 Dec;8(4):275-296. doi: 10.1007/s40506-016-0086-4. Epub 2016 Oct 11.
2
Nontuberculous Mycobacteria-Overview.
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0024-2016.
3
Rapidly Growing Mycobacteria.
Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0027-2016.
5
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.
Clin Infect Dis. 2017 Feb 1;64(3):301-308. doi: 10.1093/cid/ciw723. Epub 2016 Nov 10.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验